Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
2017 · Nature Medicine · 3,415 citations
https://doi.org/10.1038/nm.4333
S
Sean M. Devlin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
660
Papers
19.4K
Citations
58
h-index
190
i10-index
Sean M. Devlin is an academic researcher from Fred Hutch Cancer Center. The author has contributed to research in topics: Hematopoietic Stem Cell Transplantation & Acute Myeloid Leukemia Research & Multiple Myeloma Research and Treatments. The author has an h-index of 58, co-authored 561 publications.
ORCID: 0000-0002-6801-720XPapers by this author
worksImplications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
2020 · Nature Medicine · 618 citations
https://doi.org/10.1038/s41591-020-1008-z
Unified classification and risk-stratification in Acute Myeloid Leukemia
2022 · Nature Communications · 162 citations
https://doi.org/10.1038/s41467-022-32103-8
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results
2023 · Nature Medicine · 152 citations
https://doi.org/10.1038/s41591-023-02404-6
Multicolor Flow Cytometry and Multigene Next-Generation Sequencing Are Complementary and Highly Predictive for Relapse in Acute Myeloid Leukemia after Allogeneic Transplantation
2017 · Biology of Blood and Marrow Transplantation · 139 citations
https://doi.org/10.1016/j.bbmt.2017.03.017
High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation
2014 · Blood · 121 citations
https://doi.org/10.1182/blood-2014-06-584789
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat